Sena A - Search Results

1

Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis.

Sena A, Pedrosa R, Ferret-Sena V, Almeida R, Andrade ML, Morais MG, Couderc R. Sena A, et al. Clin Chem Lab Med. 2000 Mar;38(3):209-13. doi: 10.1515/CCLM.2000.030. Clin Chem Lab Med. 2000. PMID: 10905756

2

Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study.

Sena A, Macedo A, Ferret-Sena V, Capela C, Pedrosa R. Sena A, et al. Front Neurol. 2019 Feb 5;10:60. doi: 10.3389/fneur.2019.00060. eCollection 2019. Front Neurol. 2019. PMID: 30787904 Free PMC article.

3

Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta.

Sena A, Bendtzen K, Cascais MJ, Pedrosa R, Ferret-Sena V, Campos E. Sena A, et al. J Neurol. 2010 Oct;257(10):1703-7. doi: 10.1007/s00415-010-5606-4. Epub 2010 Jun 4. J Neurol. 2010. PMID: 20524007 Clinical Trial.

4

Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.

Sena A, Couderc R, Vasconcelos JC, Ferret-Sena V, Pedrosa R. Sena A, et al. J Neurol Sci. 2012 Jun 15;317(1-2):47-51. doi: 10.1016/j.jns.2012.02.033. Epub 2012 Mar 28. J Neurol Sci. 2012. PMID: 22459356

5

Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.

Sena A, Pedrosa R, Ferret-Sena V, Cascais MJ, Roque R, Araújo C, Couderc R. Sena A, et al. Mult Scler. 2008 Jul;14(6):857-9. doi: 10.1177/1352458508089687. Epub 2008 Jun 23. Mult Scler. 2008. PMID: 18573825 Clinical Trial.

6

Multiple sclerosis and intrathecal IgA synthesis.

Sena A, Rosado P, Ferret-Sena V, Coimbra J, Schuller E, Sindic CJ. Sena A, et al. Acta Neurol Belg. 1997 Mar;97(1):36-8. Acta Neurol Belg. 1997. PMID: 9107343

7

Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.

Sena A, Couderc R, Ferret-Sena V, Pedrosa R, Andrade ML, Araujo C, Roque R, Cascais MJ, Morais MG. Sena A, et al. Eur J Neurol. 2009 Jul;16(7):832-7. doi: 10.1111/j.1468-1331.2009.02603.x. Epub 2009 Mar 26. Eur J Neurol. 2009. PMID: 19473356 Free article.

8

Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.

Ferret-Sena V, Capela C, Sena A. Ferret-Sena V, et al. Among authors: sena a. Int J Mol Sci. 2018 Jun 1;19(6):1639. doi: 10.3390/ijms19061639. Int J Mol Sci. 2018. PMID: 29865151 Free PMC article. Review.

9

Statins for multiple sclerosis.

Sena A, Pedrosa R, Morais MG. Sena A, et al. Lancet. 2004 Jul 31-Aug 6;364(9432):412; author reply 412-3. doi: 10.1016/S0140-6736(04)16752-4. Lancet. 2004. PMID: 15288728 No abstract available.

10

Therapeutic potential of lovastatin in multiple sclerosis.

Sena A, Pedrosa R, Graça Morais M. Sena A, et al. J Neurol. 2003 Jun;250(6):754-5. doi: 10.1007/s00415-003-1070-8. J Neurol. 2003. PMID: 12862032 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results